<DOC>
	<DOCNO>NCT00445783</DOCNO>
	<brief_summary>RATIONALE : A study evaluate patient ' lifestyle , skin , blood tissue sample may help doctor understand risk factor melanoma relapse . PURPOSE : This clinical trial study risk factor melanoma family melanoma .</brief_summary>
	<brief_title>Study Families With Melanoma</brief_title>
	<detailed_description>OBJECTIVES : Primary - Determine lifestyle factor gene govern relapse melanoma . Secondary - Compare sun exposure gene cause melanoma patient melanoma vs healthy participant . - Assess unusual mole relate sun exposure gene cause melanoma . OUTLINE : This multicenter , cohort study . Patients healthy participant complete lifestyle questionnaire mail telephone . Some patients* healthy participant undergo skin examination count mole classify skin type ( e.g. , degree freckle wrinkle indicative sun damage ) . NOTE : *Patients diagnose primary invasive melanoma September 2005 need consent skin examination . Patients healthy participant also undergo blood collection lymphocyte analysis , DNA extraction , measurement mineral , vitamin , beta carotene . Tissue sample original diagnosis examine immunohistochemistry gene expression mutation , include CDKN2A CDK4 . Patients healthy participant follow annually . Peer review funded endorsed Cancer Research UK PROJECTED ACCRUAL : A total 3,700 patient healthy participant accrue study .</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Meets 1 follow criterion : Newly diagnose primary invasive melanoma ( patient group ) Lentigo maligna malignant melanoma allow Rare variant melanoma allow , include follow : Acral lentiginous Subungual Ear , nose , throat Oropharyngeal Perineal Vaginal Vulval Rectal Nodal know primary Patients undergoing sentinel node biopsy eligible No situ melanoma , melanocytic intraepidermal neoplasia , ocular melanoma Healthy participant meeting either follow criterion ( control group ) : Relative patient diagnose melanoma September 2005 Healthy volunteer age sexmatched patient diagnosed melanoma October 2005 PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>lentigo maligna malignant melanoma</keyword>
	<keyword>stage IV melanoma</keyword>
	<keyword>acral lentiginous malignant melanoma</keyword>
	<keyword>nodular malignant melanoma</keyword>
	<keyword>stage IA melanoma</keyword>
	<keyword>stage IB melanoma</keyword>
	<keyword>stage IIA melanoma</keyword>
	<keyword>stage IIB melanoma</keyword>
	<keyword>stage IIC melanoma</keyword>
	<keyword>stage IIIA melanoma</keyword>
	<keyword>stage IIIB melanoma</keyword>
	<keyword>stage IIIC melanoma</keyword>
</DOC>